Pascal and Francis Bibliographic Databases


Search results

Your search



A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 9156

  • Page / 367

Selection :

  • and

Magnesium and hyperlipemiasLAIRES, M. J; PEREIRA, T. G; HALPERN, M. J et al.Magnesium. 1983, Vol 2, Num 4-6, pp 250-252, issn 0252-1156Article

Increased lysolecithin acyltransferase activity in the plasma of type II hyperlipoproteinemic patientsSUBBAIAH, P. V; OGILVIE, J. T.Lipids. 1984, Vol 19, Num 2, pp 80-84, issn 0024-4201Article

New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemiaYAMAMURA, T; YAMAMOTO, A; SUMIYOSHI, T et al.The Journal of clinical investigation. 1984, Vol 74, Num 4, pp 1229-1237, issn 0021-9738Article

Preliminary report: treatment of type 3 hyperlipoproteinemia with mevinolinEAST, C. A; GRUNDY, S. M; BILHEIMER, D. W et al.Metabolism, clinical and experimental. 1986, Vol 35, Num 2, pp 97-98, issn 0026-0495Article

Hyperlipoprotéinémies athérogènes: «dépistage et prévention» = Hyperlipoprotéinemia and atherosclerosis (screening and prevention)CASTELLI, W. P; DE GENNES, J. L; MARHIC, PR et al.Gazette médicale de France (1969). 1985, Num 30, pp 3-24, issn 0016-5557Serial Issue

Relationship between corneal arcus and hyperlipidaemia is clarified by studies in flamilial hypercholesterolaemiaWINDER, A. F.British journal of ophthalmology. 1983, Vol 67, Num 12, pp 789-794, issn 0007-1161Article

The association of hyperlipoproteinemia with dysimmunoglobulinemiaBRINKSCHMIDT, T; HEUCK, C. C; SCHLIERF, G et al.Atherosclerosis. 1986, Vol 59, Num 3, pp 323-328, issn 0021-9150Article

Traitement diététique des hyperlipoprotéinémies = Dietary treatment of primary hyperlipoproteinemiaLOUIS, J; ANTOINE, J. M; POINTEL, J. P et al.La Semaine des hôpitaux de Paris. 1983, Num 32, pp 2273-2278, issn 0037-1777Article

Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemiaKOWALSKI, J; OKOPIEN, B; MADEJ, A et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 6, pp 241-247, issn 0946-1965, 7 p.Article

Heterogeneity of lipoprotein electrophoretic patterns in patients with type IIa hyperlipoproteinemiaHOEG, J. M; PAPADOPOULOS, N. M; GREGG, R. E et al.Clinical chemistry (Baltimore, Md.). 1983, Vol 29, Num 8, pp 1459-1462, issn 0009-9147Article

Decreased number of PGD2 binding sites on platelets from patients with type IIa hyperlipoproteinemiaABBATE, R; MODESTI, P. A; FORTINI, A et al.Atherosclerosis. 1985, Vol 54, Num 2, pp 167-175, issn 0021-9150Article

Type I hyperlipoproteinemia presenting as sudden death in infancyPOTTER, J. M; HILTON, J. M. N.Australian and New Zealand journal of medicine. 1983, Vol 13, Num 4, pp 381-383, issn 0004-8291Article

The HyperlipoproteinemiasPATSCH, W; PATSCH, J. R; GOTTO, A. M et al.The Medical clinics of North America. 1989, Vol 73, Num 4, pp 859-893, issn 0025-7125, 35 p.Article

Acylation-stimulatory activity in hyperapobetalipoproteinemic fibroblasts : enhanced cholesterol esterification with another serum basic protein, BP IIKWITEROVICH, P. JR; MOTEVALLI, M; MILLER, M et al.Proceedings of the National Academy of Sciences of the United States of America. 1990, Vol 87, Num 22, pp 8980-8984, issn 0027-8424, 5 p.Article

Prevalence of femoral atherosclerosis in asymptomatic men with hyperlipoproteinaemiaRUHN, G; ERIKSON, U; OLSSON, A. G et al.Journal of internal medicine. 1989, Vol 225, Num 5, pp 317-323, issn 0954-6820, 7 p.Article

Intérèt de la détermination du LDL-cholestérol dans les hyperlipoprotéinémies = Value of LDL-cholesterol determination in hyperlipoproteinaemiaALCINDOR, L. G; AALAM, H; PIOT, M. C et al.La Presse médicale (1983). 1983, Vol 12, Num 37, pp 2319-2321, issn 0755-4982Article

Sarcoidosis and acquired type II-b hyperlipoproteinaemiaUMEKI, S; NIKI, Y; SOEJIMA, R et al.The European respiratory journal. 1988, Vol 1, Num 6, pp 558-559, issn 0903-1936Article

Efficacy of a simplified screening procedure for hyperlipoproteinemiasLEHMANN, C. A; TREANOR, W. J; MALCHIODI, L et al.Journal of medical technology. 1985, Vol 2, Num 3, pp 174-176, issn 0741-5397Article

Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patientsAVIRAM, M.Biochemical medicine. 1983, Vol 30, Num 1, pp 111-118, issn 0006-2944Article

Athérome et hétérogénéité des lipoprotéines: l'aspect médical = Atheroma and lipoprotein heterogeneity: medical aspectDOUSTE-BLAZY, P; CHOLLET, F; PERRET, B et al.Annales de biologie clinique (Paris). 1986, Vol 44, Num 4, pp 353-360, issn 0003-3898Article

Soybean protein diets in the management of type II hyperlipoproteinaemiaVERRILLO, A; DE TERESA, A; CARANDENTE GIARRUSSO, P et al.Atherosclerosis. 1985, Vol 54, Num 3, pp 321-331, issn 0021-9150Article

Vitamin E and lipoproteins in hyperlipoproteinemiaLAMBERT, D; MOUROT, J.Atherosclerosis. 1984, Vol 53, Num 3, pp 327-330, issn 0021-9150Article

Zur Wirkung von β-Pyridylcarbinol auf Lipide und Lipoproteine bei primärer Typ IIa-Hyperlipoproteinämie = L'action de β-pyridimylcarbinol sur les lipides et sur les lipoprotéines dans le type IIa d'hyperlipoprotéinémie = Effect of β-pyridylcarbinol on lipids and lipoproteins in primary hyperlipoproteinemia type IIaHUTT, V; WECHSLER, J. G; KLÖR, H. U et al.Arzneimittel-Forschung. 1983, Vol 33, Num 12, pp 1682-1684, issn 0004-4172Article

Pseudocholinesterase/high-density lipoprotein cholesterol ratio in serum of normal persons and of hyperlipoproteinemicsJAIN, R; KUTTY, K. M; HUANG, S.-N et al.Clinical chemistry (Baltimore, Md.). 1983, Vol 29, Num 6, pp 1031-1033, issn 0009-9147Article

Zusammensetzung der Lipoproteinfraktionen VLDL, LDL und HDL bei Hyperlipämikern der Typen IIa, IIb, III, IV und V im Vergleich zu Stoffwechselgesunden = Composition de VLDL, LDL et HDL dans l'hyperlipémie de type IIa, IIb, III, IV et V et dans la normolipémie = Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV and V hyperlipaemic patients and in normal individualsHUTT, V; KLÖR, H. U; WECHSLER, J. G et al.Journal of clinical chemistry and clinical biochemistry. 1984, Vol 22, Num 2, pp 141-146, issn 0340-076XArticle

  • Page / 367